Importer of Controlled Substances; Notice of Registration, 34968 [E6-9415]
Download as PDF
<![CDATA[
34968
Federal Register / Vol. 71, No. 116 / Friday, June 16, 2006 / Notices
Cisco Systems, Inc., 170 West Tasman
Drive, San Jose, California 95134.
Lucent Technologies, Inc., 600
Mountain Avenue, Murray Hill, New
Jersey 07974.
´
Alcatel S.A., 54, rue La Boetie, 75008,
Paris, France.
Alcatel USA, Inc., 3400 W. Plano
Parkway, Plano, Texas 75075.
PMC–Sierra, Inc., 3975 Freedom Circle,
Santa Clara, CA 95054.
wwhite on PROD1PC61 with NOTICES
(c) The Commission investigative
attorney, party to this investigation, is
Steven R. Pedersen, Esq., Office of
Unfair Import Investigations, U.S.
International Trade Commission, 500 E
Street, SW., Suite 401, Washington, DC
20436; and
(3) For the investigation so instituted,
the Honorable Robert L. Barton, Jr. is
designated as the presiding
administrative law judge.
Responses to the amended complaint
and the notice of investigation must be
submitted by the named respondents in
accordance with § 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(d) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the amended complaint
and the notice of investigation.
Extensions of time for submitting
responses to the amended complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
amended complaint and in this notice
may be deemed to constitute a waiver of
the right to appear and contest the
allegations of the amended complaint
and this notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the amended complaint and
this notice and to enter an initial
determination and a final determination
containing such findings, and may
result in the issuance of a limited
exclusion order or cease and desist
order or both directed against the
respondent.
Issued: June 9, 2006.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E6–9416 Filed 6–15–06; 8:45 am]
BILLING CODE 7020–02–P
VerDate Aug<31>2005
18:25 Jun 15, 2006
Jkt 208001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated January 20, 2006 and
published in the Federal Register on
January 27, 2006 (71 FR 4612), Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78664, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
Schedule I and II:
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ...................
N-Ethylamphetamine (1475) .........
Gamma
hydroxybutyric
acid
(2010).
Ibogaine (7260) .............................
Tetrahydrocannabinols (7370) ......
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ....
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Etorphine (except HCI) (9056) .....
Heroin (9200) ................................
Pholcodine (9314) .........................
Amphetamine (1100) ....................
Methamphetamine (1105) .............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Meperidine (9230) .........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ....................
I
I
I
I
I
I
I
I
I
I
I
Frm 00099
Fmt 4703
Sfmt 4703
Dated: June 7, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–9415 Filed 6–15–06; 8:45 am]
BILLING CODE 4410–09–P
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
PO 00000
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Cerilliant Corporation to import the
basic class of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Cerilliant Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substances
listed.
NEIGHBORHOOD REINVESTMENT
CORPORATION
Neighborworks America Annual
Meeting of the Board of Directors;
Sunshine Act
TIME & DATE: 3 p.m. Tuesday, June 20,
2006.
1325 G Street, NW., Suite 800,
Boardroom, Washington, DC 20005.
PLACE:
STATUS:
Open.
FOR FURTHER INFORMATION CONTACT:
Jeffrey T. Bryson, General Counsel/
Secretary, (202) 220–2372;
jbryson@nw.org.
Agenda
I. Call to Order
II. Approval of the Minutes
III. Summary Committee Reports
IV. Resolutions of Appreciation
V. Chief Executive Officer’s
Management Report
VI. Adjournment
Jeffrey T. Bryson,
General Counsel/Secretary.
[FR Doc. 06–5503 Filed 6–14–06; 10:53 am]
BILLING CODE 7570–02–M
E:\FR\FM\16JNN1.SGM
16JNN1
]]>Agencies
[Federal Register Volume 71, Number 116 (Friday, June 16, 2006)]
[Notices]
[Page 34968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9415]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated January 20, 2006 and published in the Federal
Register on January 27, 2006 (71 FR 4612), Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock, Texas 78664, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of the basic classes of controlled substances listed in
Schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)............................ I
Methcathinone (1237)........................ I
N-Ethylamphetamine (1475)................... I
Gamma hydroxybutyric acid (2010)............ I
Ibogaine (7260)............................. I
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
3,4-Methylenedioxyamphetamine (7400)........ I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405).... I
4-Methoxyamphetamine (7411)................. I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
Etorphine (except HCI) (9056)............... I
Heroin (9200)............................... I
Pholcodine (9314)........................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Methylphenidate (1724)...................... II
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Benzoylecgonine (9180)...................... II
Ethylmorphine (9190)........................ II
Meperidine (9230)........................... II
Methadone (9250)............................ II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................. II
Thebaine (9333)............................. II
Levo-alphacetylmethadol (9648).............. II
Oxymorphone (9652).......................... II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical reference
standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Cerilliant Corporation to import the basic class of
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Cerilliant Corporation to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic class of controlled substances listed.
Dated: June 7, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-9415 Filed 6-15-06; 8:45 am]
BILLING CODE 4410-09-P
